Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ZEPP
  4. Zepp Health Corporation (ZEPP) Q3 2025 Earnings Call Transcript

Zepp Health Corporation (ZEPP) Q3 2025 Earnings Call Transcript

ZEPP logo
ZEPP
Zepp Health Corp
4.96 USD
-9.32%

Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

Overview

The earnings call summary indicates strong revenue growth, improved gross margins, and a solid cash position. Product launches and market expansion plans are promising. The Q&A reveals supply constraints but management is optimistic about resolving these issues and anticipates strong holiday demand. Conservative guidance and positive feedback on new products suggest potential growth. Despite some uncertainties, the overall sentiment is positive, likely resulting in a stock price increase.

Key Financial Performance

Revenue Revenue increased 78.5% year-over-year to $75.8 million. This growth was driven by strong market reception for the T-Rex 3 Pro launched in September, as well as continued strength from Balance 2 and Helio Strap introduced in Q2. Entry-level models like Bip 6 and Active 2 also contributed steady sales volume. However, supply constraints for Helio Strap and typhoon-related shipment delays partially offset these gains.

Gross Margin Gross margin was 38.2% (or 39.4% excluding tariffs), representing a 2.4% decrease compared to 40.6% in Q3 2024. The decline was due to lower pricing for entry-level products, Prime Day discounts, and promotional pricing for end-of-life cycle models. However, the T-Rex 3 Pro launch helped offset some of these impacts. Sequentially, gross margin improved by 2% compared to Q2 2025 due to a favorable product mix and new product contributions.

Operating Expenses Adjusted operating expenses totaled $28.6 million, stable year-over-year but increased by $2.2 million quarter-over-quarter due to foreign exchange rate fluctuations. The company maintained a cost-conscious approach, targeting a run rate of approximately $25 million per quarter for operating costs.

R&D Expenses Adjusted R&D expenses were $10.2 million, up 1.5% year-over-year and stable quarter-over-quarter. The increase reflects continued investment in innovation while ensuring resource efficiency.

Selling and Marketing Expenses Adjusted selling and marketing expenses were $11.9 million, up 0.5% year-over-year but down 1% quarter-over-quarter. The year-over-year increase was due to front-loaded brand and channel investments ahead of the holiday season.

G&A Expenses Adjusted G&A expenses were $6.5 million, flat year-over-year with a modest sequential increase due to foreign exchange fluctuations.

Operating Profitability The company achieved operating breakeven in Q3 2025, a significant improvement from an adjusted operating loss of $11.3 million in Q3 2024. This marks a key milestone towards sustained profitability.

Cash Balance Cash balance increased to $103 million from $95 million in Q2 2025, driven by improved working capital and operational efficiency. Inventory levels also increased slightly to prepare for upcoming product launches and the Q4 peak season.

You have reached the limit. Sign up to access full content
Get started

Operating Highlights

Amazfit T-Rex 3 Pro: Launched in September, designed for endurance athletes and outdoor adventures. Features enhanced durability, advanced navigation, and outdoor safety. Highlighted during UTMB race week, with elite trail runners using it for real-time checking and recovery optimization.

Balance 2 and Helio Strap: Continued strong performance following Q2 debut. Updates include new training modes, improved data visualization, and refined UI features.

Entry-level Bip 6 and Active 2 series: Maintained steady sales across global channels, solidifying Amazfit's position across diverse user tiers.

BioCharge feature on Balance 2: Introduced a personalized body energy management feature integrating biometric data streams to calculate energy levels.

Global expansion: Strengthened presence in global and regional sports communities through partnerships with HYROX and participation in events like HYROX Beijing.

Japanese market: Welcomed Ota Aoi as Amazfit's first Japanese brand ambassador, expanding presence in Japan.

Revenue growth: Achieved 78.5% year-over-year revenue growth in Q3 2025, reaching $75.8 million.

Gross margin improvement: Sequentially improved gross margin from 36.2% to 38% due to effective mix management and margin improvement initiatives.

Operational breakeven: Achieved operating breakeven in Q3 2025, a significant improvement from Q3 2024's adjusted operating loss of $11.3 million.

Cash balance: Increased cash balance to $103 million as of September 30, 2025, driven by improved working capital and operational efficiency.

Acquisition of Wild.AI: Acquired core assets from Wild.AI, a women's wellness platform, to enhance personalized coaching experiences for female athletes.

Technology ecosystem: Enhanced Zepp OS and Zepp Pro with AI-driven training insights and expanded integration with platforms like Strava and TrainingPeaks.

Capital structure optimization: Refinanced short-term debt into long-term instruments, reducing near-term liquidity pressure and enhancing capital structure.

You have reached the limit. Sign up to access full content
Get started

Risk or Challenges

Macroeconomic Landscape: The macroeconomic environment has impacted Q3 performance, requiring adjustments to the business model and long-term supply chain optimizations.

Tariff Risks: Potential tariff-related risks have led to increased inventory levels to mitigate their impact.

Memory Chip Supply Constraints: Memory chip prices have more than doubled due to supply constraints and increased demand, particularly in the AI sector, posing cost challenges.

Helio Strap Supply Constraints: Supply constraints for the Helio Strap partially offset positive sales performance.

Typhoon-Related Shipment Delays: Typhoon-related delays impacted shipments late in the quarter.

Gross Margin Pressure: Gross margin declined year-over-year due to lower pricing of entry-level products, Prime Day discounts, and end-of-life cycle promotions.

Foreign Exchange Rate Fluctuations: Foreign exchange rate fluctuations increased operating expenses by $2.2 million quarter-over-quarter.

Debt Levels: Although debt restructuring has improved liquidity, the company still carries long-term and short-term debt, which requires ongoing management.

You have reached the limit. Sign up to access full content
Get started

Guidance & Outlook

Revenue Expectations: The company anticipates Q4 2025 revenue to be between USD 82 million and USD 86 million, representing a 38% to 45% year-over-year growth.

Margin Projections: The company expects further progress in its margin expansion strategy initiated in the second half of 2023 as new product launches gain scale.

Capital Expenditures and Inventory: The company has strategically increased inventory in key product lines to meet strong customer demand and mitigate potential risks, particularly ahead of the Q4 consumer electronics peak season.

Market Trends and Business Segment Performance: The company is optimistic about sustaining top-line momentum and achieving greater operating leverage, supported by a strong product pipeline, margin improvement initiatives, and disciplined execution despite a challenging macroeconomic environment.

Strategic Plans and Product Launches: The company plans to continue expanding its product portfolio, including the T-Rex 3 Pro 44-millimeter version and other upcoming launches, to drive top-line growth into the holiday season and beyond.

You have reached the limit. Sign up to access full content
Get started

Shareholder Return Plan

Share Buyback Program: We maintained our commitment to our share buyback program, underscoring our confidence in Zepp Health's long-term fundamentals and growth trajectory and our focus on delivering value for shareholders.

You have reached the limit. Sign up to access full content
Get started

Key Q&A

Q:The press release mentioned supply constraints on the Helio Strap. Do you mind giving more color on this?
A:The supply constraints on the Helio Strap are due to a memory chip issue affecting the entire industry, leading to long lead times. Additionally, the product's popularity has caused shortages in all operating regions. A typhoon in Southeast China further tightened the supply situation. However, the company is working to resolve these issues, expecting improvements in Q4 and Q1.
Q:You don't give segmental revenues by region. But just to get an idea regarding the impact of tariffs, would you say North America still accounts for approximately 15% of total shipments?
A:North America accounts for approximately 15% to 20% of total shipments. The company employs a dual sourcing strategy, supplying most U.S. products from Vietnam, minimizing tariff impacts.
Q:With respect to product launches, was the T-Rex Pro the only product launched last quarter? Can you give us some numbers, how many launched last quarter, how many expected in Q4?
A:In Q3, the only new product launched was the T-Rex 3 Pro (48mm version). The Helio Strap and Balance 2, launched in June, were sold throughout Q3. For Q4, the T-Rex 3 Pro (44mm version) began selling on October 25th. Additional new products are planned for Q4, but details were not disclosed.
Q:Could you please give us a bit more color on the T-Rex 3 Pro launch as well as the 44-millimeter initial feedback so far, and what's your current view on the holiday season demand signals?
A:The T-Rex 3 Pro has received positive feedback, with the 48mm version performing better than its predecessor despite being priced higher. The 44mm version has shown increasing activation trends but lacks sufficient data for a trend analysis. Holiday season demand signals are positive, and the company plans to maintain momentum into Q4.
Q:Is there any reason to be extra conservative in terms of 4Q guide, given the strong new product pipeline and supply chain improvement?
A:The company remains prudent in its Q4 guidance despite strong demand and supply chain improvements. Historical guidance has been conservative but accurate. Supply constraints on products like the Helio Strap and prioritization of online channels over offline channels also contribute to this cautious approach.
Q:Could you please give us a bit more color in terms of how you want to grow your channel reach into Q4 and next year?
A:The company sees significant growth potential in both online and offline channels. Online channels, including Amazon and the company's website, are growing rapidly and will continue to play a significant role. Offline channels, such as Best Buy and Target, will be prioritized once supply constraints are resolved. Online growth offers better gross margins compared to offline.
Q:What are your underlying assumptions for price growth and volume growth in Q4, and what's your approach to discounting during this period?
A:Q4 is expected to be the highest quarter due to holiday season demand. The company aims to increase average selling prices (ASP) with higher-priced products like the Balance 2 and T-Rex 3 Pro. Gross margins are expected to grow but may be slightly offset by selective discounting and promotional events targeting specific consumers and product groups.
Q:Are there any marketing initiatives planned for Q4, and how should we think about the trajectory of sales and marketing expenses next quarter?
A:Marketing expenses are expected to remain flat at around $10-$11 million per quarter. The company will invest in marketing only if it offers a good return on investment (ROI). If opportunities arise, marketing expenses may be front-loaded to drive growth and market share.
Q:Will there be any other new product launches this year, and could management share plans for product iteration next year?
A:In Q4, the T-Rex 3 Pro (44mm version) has already launched, with additional new products planned but undisclosed. For next year, the company plans to maintain a cadence of 2-3 new product launches per quarter, focusing on different product lines each quarter. Specific details were not provided.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details about the new products planned for Q4 and next year, citing the need for patience until official announcements. Additionally, they did not provide sufficient data to analyze trends for the T-Rex 3 Pro (44mm version) due to its recent launch.
You have reached the limit. Sign up to access full content
Get started

Earnings Word Cloud

The most frequently occurring keywords in this quarter's earning call
AI analytics
AI woman
Act st
Amazfit RED
Amazfit Rex
Amazfit ambassador
Amazfit brand
Amazfit physiology
Amazfit position
Amazfit positioning
Athletes product
Balance analytics
BioCharge
Helio
Rex Pro
USD
analytics usability
competitiveness
debut
durability navigation
ecosystem
endurance
energy level
experience
feedback
hardware
margin improvement
navigation safety
platform
premium
presence sport
product development
product margin
safety feature
sport community
training mode
trust
update
value user

ZEPP Transcript

Zepp Health Corporation (ZEPP) Q1 2026 Earnings Call Transcript
Neutral6-9
Zepp Health Corporation (ZEPP) Q4 2025 Earnings Call Transcript
Positive3-16

The earnings call highlighted strong financial performance with a 10% revenue increase, improved gross margins, and a 25% rise in net income. These positive financial metrics are likely to drive a positive stock price reaction. Despite the lack of specific discussions on operational updates and shareholder returns, the strong financial results and improved cash flow suggest a positive outlook. The absence of negative sentiment in the Q&A supports this view.

Zepp Health Corporation (ZEPP) Q3 2025 Earnings Call Transcript
Positive11-5

The earnings call summary indicates strong revenue growth, improved gross margins, and a solid cash position. Product launches and market expansion plans are promising. The Q&A reveals supply constraints but management is optimistic about resolving these issues and anticipates strong holiday demand. Conservative guidance and positive feedback on new products suggest potential growth. Despite some uncertainties, the overall sentiment is positive, likely resulting in a stock price increase.

Zepp Health Corporation (ZEPP) Q2 2025 Earnings Call Transcript
Positive8-4

The earnings call reveals a strong financial performance with a 46% YoY revenue increase and improved operating loss. Despite slight gross margin decline, management anticipates future expansion. The share repurchase program reflects confidence in long-term growth. Although there are concerns about management's vague responses, the product pipeline and strategic initiatives, like tariff mitigation, are promising. Given the positive Q3 guidance and shareholder value focus, the stock price is likely to rise 2-8%.

ZEPP Report

Zepp Health Corp 6-K
6-K
2024-11-19
Zepp Health Corp 6-K
6-K
2024-10-04
Zepp Health Corp 6-K
6-K
2024-09-06
Zepp Health Corp 6-K
6-K
2024-09-04

Frequently Asked Questions

Where does this earnings call transcript come from?

All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.

How soon is the transcript available after the earnings call ends?

Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.

Is the transcript edited or altered in any way?

No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.

Why do some answers appear as “Unclear” or “Inaudible”?

When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.

Who creates the AI Summary and Key Q&A highlights shown above the transcript?

They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.

Explore More Earnings

PENG logo
PENG
2026-07-07 16:05:00
after hour
After Hours
Revenue
$478.71M
+10.05%
EPS
-$0.71
+12.70%
AI Prediction
-
AI Summary
Calendar ReportReport
KRUS logo
KRUS
2026-07-07 16:06:00
after hour
After Hours
Revenue
$85.92M
-0.40%
EPS
-$0.03
+160.00%
AI Prediction
-
AI Summary
Calendar ReportReport
SAR logo
SAR
2026-07-07 16:24:00
after hour
After Hours
Revenue
$30.78M
-2.82%
EPS
-$0.47
-12.96%
AI Prediction
-
Calendar ReportReport
EPAC logo
EPAC
2026-07-07 17:04:00
after hour
After Hours
Revenue
$167.55M
+1.86%
EPS
-$0.60
+22.45%
AI Prediction
-
Calendar ReportReport
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia